XML 83 R71.htm IDEA: XBRL DOCUMENT v3.10.0.1
SUMMARIZED CONDENSED CONSOLIDATING INFORMATION - Condensed Consolidating Statement of Cash Flows (Details) - USD ($)
$ in Thousands
6 Months Ended
Jun. 30, 2018
Jun. 30, 2017
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities $ 211,553 $ 54,282
Cash flows from investing activities:    
Acquisition of real estate (213,982) (14,456)
Origination and fundings of loans receivable (28,157) (927)
Origination and fundings of preferred equity investments (945) (76)
Additions to real estate (16,817) (1,294)
Repayments of loans receivable 38,887 1,547
Repayments of preferred equity investments 375 2,766
Investment in unconsolidated JV (354,461) 0
Net proceeds from the sales of real estate 278,201 6,099
Distribution from subsidiaries 0 0
Intercompany financing 0 0
Net cash used in investing activities (296,899) (6,341)
Cash flows from financing activities:    
Net borrowings from revolving credit facility 35,000 6,000
Principal payments on secured debt (2,128) (2,049)
Payments of deferred financing costs (12) (124)
Distributions to noncontrolling interests (72) 0
Preferred stock redemption (143,750) 0
Issuance of common stock, net (499) (3,224)
Dividends paid on common and preferred stock (164,736) (60,691)
Distribution to parent 0 0
Intercompany financing 0 0
Net cash used in financing activities (276,197) (60,088)
Net decrease in cash, cash equivalents and restricted cash (361,543) (12,147)
Effect of foreign currency translation on cash, cash equivalents and restricted cash (252) 130
Cash, cash equivalents and restricted cash, beginning of period 587,449 34,665
Cash, cash equivalents and restricted cash, end of period 225,654 22,648
Elimination    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 0 0
Cash flows from investing activities:    
Acquisition of real estate 0 0
Origination and fundings of loans receivable 0 0
Origination and fundings of preferred equity investments 0 0
Additions to real estate 0 0
Repayments of loans receivable 0 0
Repayments of preferred equity investments 0 0
Investment in unconsolidated JV 0  
Net proceeds from the sales of real estate 0 0
Distribution from subsidiaries (5,338) (4,948)
Intercompany financing 791,958 9,210
Net cash used in investing activities 786,620 4,262
Cash flows from financing activities:    
Net borrowings from revolving credit facility 0 0
Principal payments on secured debt 0 0
Payments of deferred financing costs 0 0
Distributions to noncontrolling interests 0  
Preferred stock redemption 0  
Issuance of common stock, net 0 0
Dividends paid on common and preferred stock 0 0
Distribution to parent 5,338 4,948
Intercompany financing (791,958) (9,210)
Net cash used in financing activities (786,620) (4,262)
Net decrease in cash, cash equivalents and restricted cash 0 0
Effect of foreign currency translation on cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 0 0
Cash, cash equivalents and restricted cash, end of period 0 0
Parent Company | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 204,440 49,670
Cash flows from investing activities:    
Acquisition of real estate 0 0
Origination and fundings of loans receivable 0 0
Origination and fundings of preferred equity investments 0 0
Additions to real estate (40) (12)
Repayments of loans receivable 0 0
Repayments of preferred equity investments 0 0
Investment in unconsolidated JV 0  
Net proceeds from the sales of real estate 0 0
Distribution from subsidiaries 2,669 2,474
Intercompany financing (378,485) (1,667)
Net cash used in investing activities (375,856) 795
Cash flows from financing activities:    
Net borrowings from revolving credit facility 0 0
Principal payments on secured debt 0 0
Payments of deferred financing costs 0 0
Distributions to noncontrolling interests 0  
Preferred stock redemption (143,750)  
Issuance of common stock, net (499) (3,224)
Dividends paid on common and preferred stock (164,736) (60,691)
Distribution to parent 0 0
Intercompany financing 0 0
Net cash used in financing activities (308,985) (63,915)
Net decrease in cash, cash equivalents and restricted cash (480,401) (13,450)
Effect of foreign currency translation on cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 511,670 18,168
Cash, cash equivalents and restricted cash, end of period 31,269 4,718
Operating Partnership | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 0 0
Cash flows from investing activities:    
Acquisition of real estate 0 0
Origination and fundings of loans receivable 0 0
Origination and fundings of preferred equity investments 0 0
Additions to real estate 0 0
Repayments of loans receivable 0 0
Repayments of preferred equity investments 0 0
Investment in unconsolidated JV 0  
Net proceeds from the sales of real estate 0 0
Distribution from subsidiaries 2,669 2,474
Intercompany financing (413,473) (7,543)
Net cash used in investing activities (410,804) (5,069)
Cash flows from financing activities:    
Net borrowings from revolving credit facility 35,000 6,000
Principal payments on secured debt 0 0
Payments of deferred financing costs (12) (124)
Distributions to noncontrolling interests 0  
Preferred stock redemption 0  
Issuance of common stock, net 0 0
Dividends paid on common and preferred stock 0 0
Distribution to parent (2,669) (2,474)
Intercompany financing 378,485 1,667
Net cash used in financing activities 410,804 5,069
Net decrease in cash, cash equivalents and restricted cash 0 0
Effect of foreign currency translation on cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 0 0
Cash, cash equivalents and restricted cash, end of period 0 0
Sabra Capital Corporation | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 0 0
Cash flows from investing activities:    
Acquisition of real estate 0 0
Origination and fundings of loans receivable 0 0
Origination and fundings of preferred equity investments 0 0
Additions to real estate 0 0
Repayments of loans receivable 0 0
Repayments of preferred equity investments 0 0
Investment in unconsolidated JV 0  
Net proceeds from the sales of real estate 0 0
Distribution from subsidiaries 0 0
Intercompany financing 0 0
Net cash used in investing activities 0 0
Cash flows from financing activities:    
Net borrowings from revolving credit facility 0 0
Principal payments on secured debt 0 0
Payments of deferred financing costs 0 0
Distributions to noncontrolling interests 0  
Preferred stock redemption 0  
Issuance of common stock, net 0 0
Dividends paid on common and preferred stock 0 0
Distribution to parent 0 0
Intercompany financing 0 0
Net cash used in financing activities 0 0
Net decrease in cash, cash equivalents and restricted cash 0 0
Effect of foreign currency translation on cash, cash equivalents and restricted cash 0 0
Cash, cash equivalents and restricted cash, beginning of period 0 0
Cash, cash equivalents and restricted cash, end of period 0 0
Combined Guarantor Subsidiaries | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 1,041 (1,693)
Cash flows from investing activities:    
Acquisition of real estate (29,711) (14,456)
Origination and fundings of loans receivable (1,973) (927)
Origination and fundings of preferred equity investments (945) (76)
Additions to real estate (4,660) (1,106)
Repayments of loans receivable 6,577 1,547
Repayments of preferred equity investments 375 2,766
Investment in unconsolidated JV 0  
Net proceeds from the sales of real estate 232,059 6,099
Distribution from subsidiaries 0 0
Intercompany financing 0 0
Net cash used in investing activities 201,722 (6,153)
Cash flows from financing activities:    
Net borrowings from revolving credit facility 0 0
Principal payments on secured debt 0 0
Payments of deferred financing costs 0 0
Distributions to noncontrolling interests 0  
Preferred stock redemption 0  
Issuance of common stock, net 0 0
Dividends paid on common and preferred stock 0 0
Distribution to parent 0 0
Intercompany financing (63,658) 7,543
Net cash used in financing activities (63,658) 7,543
Net decrease in cash, cash equivalents and restricted cash 139,105 (303)
Effect of foreign currency translation on cash, cash equivalents and restricted cash (146) 69
Cash, cash equivalents and restricted cash, beginning of period 37,359 2,732
Cash, cash equivalents and restricted cash, end of period 176,318 2,498
Combined Non-Guarantor Subsidiaries | Reportable Legal Entities    
Condensed Financial Statements, Captions [Line Items]    
Net cash provided by (used in) operating activities 6,072 6,305
Cash flows from investing activities:    
Acquisition of real estate (184,271) 0
Origination and fundings of loans receivable (26,184) 0
Origination and fundings of preferred equity investments 0 0
Additions to real estate (12,117) (176)
Repayments of loans receivable 32,310 0
Repayments of preferred equity investments 0 0
Investment in unconsolidated JV (354,461)  
Net proceeds from the sales of real estate 46,142 0
Distribution from subsidiaries 0 0
Intercompany financing 0 0
Net cash used in investing activities (498,581) (176)
Cash flows from financing activities:    
Net borrowings from revolving credit facility 0 0
Principal payments on secured debt (2,128) (2,049)
Payments of deferred financing costs 0 0
Distributions to noncontrolling interests (72)  
Preferred stock redemption 0  
Issuance of common stock, net 0 0
Dividends paid on common and preferred stock 0 0
Distribution to parent (2,669) (2,474)
Intercompany financing 477,131 0
Net cash used in financing activities 472,262 (4,523)
Net decrease in cash, cash equivalents and restricted cash (20,247) 1,606
Effect of foreign currency translation on cash, cash equivalents and restricted cash (106) 61
Cash, cash equivalents and restricted cash, beginning of period 38,420 13,765
Cash, cash equivalents and restricted cash, end of period $ 18,067 $ 15,432